Precision Biosciences (DTIL) Short term Debt (2021 - 2024)

Precision Biosciences (DTIL) has 3 years of Short term Debt data on file, last reported at $22.5 million in Q2 2024.

• Short term Debt for Q2 2024 came in at $22.5 million, up 0.79% year-over-year; the trailing twelve-month figure through Jun 2024 was $22.5 million (up 0.79% YoY), and the FY2023 annual result was $22.4 million, changed N/A from the prior year.
• Short term Debt steadied at $22.5 million in Q2 2024 per DTIL's latest filing, from $22.5 million in the prior quarter.
• Over five years, Short term Debt peaked at $22.5 million in Q2 2024 and troughed at $2.4 million in Q2 2021.
• A 3-year average of $16.7 million and a median of $22.4 million in 2023 frame the typical range for Short term Debt.
• On a YoY basis, Short term Debt climbed as much as 0.79% in 2024 and fell as far as 0.79% in 2024.
• A 3-year view of Short term Debt shows it stood at $2.5 million in 2021, then jumped by 813.28% to $22.4 million in 2023, then gained by 0.37% to $22.5 million in 2024.
• Business Quant data shows DTIL's Short term Debt at $22.5 million in Q2 2024, $22.5 million in Q1 2024, and $22.4 million in Q4 2023.